Tvardi Therapeutics (TVRD) Misses Q1 EPS by 73c

Tvardi Therapeutics (NASDAQ: TVRD) reported Q1 EPS of ($0.73).

For earnings history and earnings-related data on Tvardi Therapeutics (TVRD) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• Pentagon-Backed Oil Company Is Set to Vie for Chevron's Crown in Venezuela - WSJ
• Future Money Acquisition gets Nasdaq notice over late 10-Q filing